Outlook Therapeutics (FRA:41O) Days Sales Outstanding : 0.00 (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Outlook Therapeutics Days Sales Outstanding?

Outlook Therapeutics's average Accounts Receivable for the three months ended in Jun. 2024 was €0.00 Mil. Outlook Therapeutics's Revenue for the three months ended in Jun. 2024 was €0.00 Mil.

The historical rank and industry rank for Outlook Therapeutics's Days Sales Outstanding or its related term are showing as below:

During the past 10 years, Outlook Therapeutics's highest Days Sales Outstanding was 2.45. The lowest was 0.81. And the median was 1.40.

FRA:41O's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 70.69
* Ranked among companies with meaningful Days Sales Outstanding only.

Outlook Therapeutics's Days Sales Outstanding stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Outlook Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Outlook Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Outlook Therapeutics Days Sales Outstanding Chart

Outlook Therapeutics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Sales Outstanding

Get a 7-Day Free Trial

Outlook Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Outlook Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Outlook Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Outlook Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Outlook Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Outlook Therapeutics's Days Sales Outstanding falls into.

Outlook Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Outlook Therapeutics's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

	Days Sales Outstanding (A: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Outlook Therapeutics's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Outlook Therapeutics (FRA:41O) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Outlook Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Outlook Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Outlook Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Outlook Therapeutics Inc (FRA:41O) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

OTLK:USA 41O:Germany

Address

485 Route 1 South Building F, Suite 320, Iselin, NJ, USA, 08852

Website

https://www.outlooktherapeutics.com

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Outlook Therapeutics Headlines

No Headlines